Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

NCT02257047 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-10-03

No results posted yet for this study

Summary

To evaluate the effect of red yeast rice on subclinical atherosclerosis in patients with rheumatoid arthritis

Conditions

Interventions

DIETARY_SUPPLEMENT

Tea

DIETARY_SUPPLEMENT

RYR

red yeast rice

Sponsors & Collaborators

  • Chengdu PLA General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-03-31
Completion
2019-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02257047 on ClinicalTrials.gov